BR0010914A - Composto medicamento agente profilático ou terapêutico, e, uso do composto - Google Patents

Composto medicamento agente profilático ou terapêutico, e, uso do composto

Info

Publication number
BR0010914A
BR0010914A BR0010914-2A BR0010914A BR0010914A BR 0010914 A BR0010914 A BR 0010914A BR 0010914 A BR0010914 A BR 0010914A BR 0010914 A BR0010914 A BR 0010914A
Authority
BR
Brazil
Prior art keywords
compound
therapeutic agent
prophylactic
medicine prophylactic
medicine
Prior art date
Application number
BR0010914-2A
Other languages
English (en)
Inventor
Takashi Fujita
Toshihiko Fujiwara
Takashi Izumi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15340495&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0010914(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of BR0010914A publication Critical patent/BR0010914A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"COMPOSTO MEDICAMENTO AGENTE PROFILáTICO OU TERAPêUTICO, E, USO DO COMPOSTO". A presente invenção diz respeito ao cloridreto do composto 5-[4-(6-metóxi- 1 -metil- 1 H-benzimidazol-2-ilmetóxi)benzil]tiazolidin-2,4-diona da seguinte estrutura (I) que apresenta uma excelente atividade hipoglicêmica e outras.
BR0010914-2A 1999-05-24 2000-05-24 Composto medicamento agente profilático ou terapêutico, e, uso do composto BR0010914A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14351399 1999-05-24
PCT/JP2000/003325 WO2000071540A1 (en) 1999-05-24 2000-05-24 Hydrochloride of fused-heterocycle compound

Publications (1)

Publication Number Publication Date
BR0010914A true BR0010914A (pt) 2002-02-19

Family

ID=15340495

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010914-2A BR0010914A (pt) 1999-05-24 2000-05-24 Composto medicamento agente profilático ou terapêutico, e, uso do composto

Country Status (25)

Country Link
US (1) US6706746B2 (pt)
EP (1) EP1180519B1 (pt)
KR (2) KR100748053B1 (pt)
CN (1) CN1156473C (pt)
AT (1) ATE294799T1 (pt)
AU (1) AU763731B2 (pt)
BR (1) BR0010914A (pt)
CA (1) CA2375017C (pt)
CZ (1) CZ297927B6 (pt)
DE (1) DE60019919T2 (pt)
DK (1) DK1180519T3 (pt)
ES (1) ES2240099T3 (pt)
HK (1) HK1042087B (pt)
HU (1) HU229340B1 (pt)
IL (1) IL146568A0 (pt)
MX (1) MXPA01012044A (pt)
NO (1) NO321578B1 (pt)
NZ (1) NZ515570A (pt)
PL (1) PL209389B1 (pt)
PT (1) PT1180519E (pt)
RU (1) RU2214410C2 (pt)
TR (1) TR200103353T2 (pt)
TW (1) TWI284533B (pt)
WO (1) WO2000071540A1 (pt)
ZA (1) ZA200109576B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
ATE341343T1 (de) 2000-12-26 2006-10-15 Sankyo Co Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel
US6756399B2 (en) * 2001-06-29 2004-06-29 The United States Of America As Represented By The Department Of Health And Human Services Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents
WO2003082865A1 (en) * 2002-04-01 2003-10-09 Sankyo Company, Limited Medicinal antitumor composition
TW200408628A (en) * 2002-08-02 2004-06-01 Sankyo Co Resorcinol and its derivatives
US7781464B2 (en) * 2003-01-17 2010-08-24 Bexel Pharmaceuticals, Inc. Heterocyclic diphenyl ethers
US6794401B2 (en) * 2003-01-17 2004-09-21 Bexel Pharmaceuticals, Inc. Amino acid phenoxy ethers
US7521465B2 (en) * 2003-01-17 2009-04-21 Bexel Pharmaceuticals, Inc. Diphenyl ether derivatives
JPWO2004106542A1 (ja) 2003-05-29 2006-07-20 三共株式会社 インスリン抵抗性改善剤及びそのスクリーニング方法
US7087576B2 (en) * 2003-10-07 2006-08-08 Bexel Pharmaceuticals, Inc. Dipeptide phenyl ethers
CN1870997B (zh) * 2003-10-24 2011-05-04 参天制药株式会社 角膜结膜病变的治疗剂
EP1566202A1 (en) * 2004-02-23 2005-08-24 Sahltech I Göteborg AB Use of resistin antagonists in the treatment of rheumatoid arthritis
EP1731170A1 (en) * 2004-03-29 2006-12-13 Sankyo Company, Limited Therapeutic agent for diabetes containing insulin resistance improving agent
TW200608967A (en) 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent
WO2006064744A1 (ja) * 2004-12-13 2006-06-22 Daiichi Sankyo Company, Limited 糖尿病の治療のための医薬組成物
BRPI0519015A2 (pt) * 2004-12-15 2008-12-23 Daiichi Sankyo Co Ltd composiÇço farmacÊutica, agente profilÁtico ou agente terapÊutico, agentes para melhorar a funÇço das cÉlulas b no pÂncreas, e para a reduÇço da razço da hemoglobina glicosilada, e, usos da 5-[4-(6-metàxi-1-metil-1h-benzimidazol-2-ilmetàxi)benzi l] tiazolidina-2,4-diona ou de um sal farmacologicamente aceitÁvel da mesma e de um inibidor de fbpase, e do 2-amino-5-isobutil-4-[2-[5-(n,n'-bis((s)-1etoxicarbonil)eti l) fosfonamido] furanil} tiazol ou de um sal farmacologicamente aceitÁvel do mesmo
TW200637856A (en) * 2005-01-24 2006-11-01 Sankyo Co Process for producing thiazolidinedion compound and intermediate thereof
EP1889618A4 (en) * 2005-05-27 2010-11-24 Daiichi Sankyo Co Ltd Combined drug for treating diabetes
EP1902713A4 (en) * 2005-07-08 2009-05-13 Daiichi Sankyo Co Ltd A PHIAZEUTIC COMPOSITION CONTAINING A THIAZOLIDINDEIDE COMPOUND
TW200738266A (en) * 2005-09-29 2007-10-16 Sankyo Co Pharmaceutical agent containing insulin resistance improving agent
EP1964575B1 (en) 2005-11-28 2015-09-23 Senju Pharmaceutical Co., Ltd. Pharmaceutical comprising ppar agonist
TW200838512A (en) * 2007-02-08 2008-10-01 Daiichi Sankyo Co Ltd Crystalline forms of a thiazolidinedione compound and manufacturing methods thereof
AU2008239179B2 (en) * 2007-04-05 2011-02-24 Daiichi Sankyo Company, Limited Fused bicyclic heteroaryl derivatives
US8802705B2 (en) 2007-05-21 2014-08-12 Senju Pharmaceutical Co., Ltd. Pharmaceutical containing PPAR delta agonist
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
KR20110123253A (ko) 2009-03-05 2011-11-14 다이이찌 산쿄 가부시키가이샤 피리딘 유도체
CA2941562C (en) 2013-03-14 2021-09-21 Deuterx, Llc Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
US10188639B2 (en) 2014-01-15 2019-01-29 Deuterx, Llc Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
CZ293016B6 (cs) * 1995-06-01 2004-01-14 Sankyo Company Limited Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
US5798375A (en) 1995-07-03 1998-08-25 Sankyo Company, Limited Treatment of arteriosclerosis and xanthoma
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
HUP0202340A3 (en) * 1999-07-19 2006-03-28 Sankyo Company Ltd Chuo Ku Pharmaceutical compositions containing condensed heterocyclic compounds as active ingredient and their use

Also Published As

Publication number Publication date
PL351650A1 (en) 2003-05-19
EP1180519A1 (en) 2002-02-20
KR20010113972A (ko) 2001-12-28
KR100783348B1 (ko) 2007-12-07
DK1180519T3 (da) 2005-06-13
US6706746B2 (en) 2004-03-16
KR20070034112A (ko) 2007-03-27
HUP0201334A2 (en) 2002-10-28
NZ515570A (en) 2003-11-28
HU229340B1 (en) 2013-11-28
TWI284533B (en) 2007-08-01
DE60019919T2 (de) 2006-02-16
NO20015712L (no) 2001-12-20
ES2240099T3 (es) 2005-10-16
TR200103353T2 (tr) 2002-04-22
CN1364168A (zh) 2002-08-14
CA2375017A1 (en) 2000-11-30
IL146568A0 (en) 2002-07-25
NO321578B1 (no) 2006-06-06
EP1180519A4 (en) 2002-07-10
EP1180519B1 (en) 2005-05-04
RU2214410C2 (ru) 2003-10-20
HK1042087B (en) 2005-09-09
CN1156473C (zh) 2004-07-07
WO2000071540A1 (en) 2000-11-30
PT1180519E (pt) 2005-06-30
MXPA01012044A (es) 2002-05-06
HUP0201334A3 (en) 2002-11-28
KR100748053B1 (ko) 2007-08-09
CZ20014182A3 (cs) 2002-04-17
HK1042087A1 (en) 2002-08-02
PL209389B1 (pl) 2011-08-31
ATE294799T1 (de) 2005-05-15
US20020111373A1 (en) 2002-08-15
DE60019919D1 (de) 2005-06-09
AU4948700A (en) 2000-12-12
AU763731B2 (en) 2003-07-31
NO20015712D0 (no) 2001-11-23
CZ297927B6 (cs) 2007-05-02
ZA200109576B (en) 2003-02-20
CA2375017C (en) 2009-05-19

Similar Documents

Publication Publication Date Title
BR0010914A (pt) Composto medicamento agente profilático ou terapêutico, e, uso do composto
DE60124684D1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
DE60138948D1 (de) Medizinische aerosolformulierung von antidiabetika
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
SE0001899D0 (sv) New compounds
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
DE60022756D1 (de) Hautpflegezusammensetzung
NO952309L (no) Anvendelse av riluzol ved behandling av Parkinsons sykdom og Parkinsonske syndromer
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
BR9809968A (pt) Aplicação de derivados tiazolidinadiona no tratamento da pcos e diabetes gestacional
DE69721679D1 (de) Antimikrobielle Zusammensetzung.
KR970706002A (ko) 남성의 상대적 안드로겐 결핍증 치료를 위한 약제의 제조에 있어서 아로마타제 억제제의 용도(Use of Aromatase Inhibitors in the Preparation of a Drug for Treating a Relative Androgen Deficiency in Men)
SE9800806D0 (sv) Användning av kollagenas
DK261490D0 (da) New pharmaceutical compound
BR0114196A (pt) Formas polimórficas de maleato de 5-[4-[2-[n-metil-n-(2-piridil) amino]etóxi]benzil]tiazolidina-2,4-diona e processo para a preparação das mesmas.
BR0309256A (pt) Sistemas de liberação responsivos à temperatura
HUP9802971A1 (hu) Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére
BR0013353A (pt) Combinação de substância ativa com clonidina
DE60128100D1 (de) Analgetisches arzneimittel
MA28072A1 (fr) Ecorces de levures pour le traitement ou la prevention de l'hyperglycemie ou pour la stabilisation de la glycemie
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
NO20012310L (no) Optisk aktiv pyridyl-4H-1,2,4-oksazdiazinderivat og dets anvendelse ved behandling av karsykdommer
PT986386E (pt) Uso de derivados heterociclicos aromaticos com azoto no tratamento topico de doencas dos tecidos epiteliais
NZ516620A (en) 1,4-substituted 4,4-diaryl cyclohexanes

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]